Spots Global Cancer Trial Database for cyclosporin a
Every month we try and update this database with for cyclosporin a cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Allo-HSCT With Alternative Donor in Treatment of Hematologic Malignancy | NCT02487069 | Acute Leukemia Chronic Myeloid... Myelodysplastic... | HSCT from MSD HSCT from MUD HSCT from HRD Cyclosporin A Methotrexate Antithymocyte g... Mycophenolate m... | 18 Years - 60 Years | Nanfang Hospital, Southern Medical University | |
| Allo-HSCT With Alternative Donor in Treatment of Hematologic Malignancy | NCT02487069 | Acute Leukemia Chronic Myeloid... Myelodysplastic... | HSCT from MSD HSCT from MUD HSCT from HRD Cyclosporin A Methotrexate Antithymocyte g... Mycophenolate m... | 18 Years - 60 Years | Nanfang Hospital, Southern Medical University | |
| A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological Malignancies | NCT04547049 | Leukemia | Cytarabine Busulfan Cyclophosphamid... Me-CCNU Rabbit antithym... Allogeneic HSCT Cyclosporin A Mycophenolate M... MTX | 14 Years - 60 Years | First Affiliated Hospital of Zhejiang University | |
| Donor Natural Killer Cells and Aldesleukin in Treating Patients w/High Risk AML Undergoing Donor Stem Cell Transplant | NCT00303667 | Acute Myelogeno... | aldesleukin natural killer ... cyclophosphamid... fludarabine pho... allogeneic hema... total body irra... Thymoglobulin Cyclosporin A cyclophosphamid... fludarabine pho... | 18 Years - 70 Years | Masonic Cancer Center, University of Minnesota | |
| Allo-HSCT With Alternative Donor in Treatment of Hematologic Malignancy | NCT02487069 | Acute Leukemia Chronic Myeloid... Myelodysplastic... | HSCT from MSD HSCT from MUD HSCT from HRD Cyclosporin A Methotrexate Antithymocyte g... Mycophenolate m... | 18 Years - 60 Years | Nanfang Hospital, Southern Medical University | |
| Treatment of Myelodysplastic Syndrome (MDS) With Cytokine-Immunotherapy for Low-Risk MDS | NCT00520468 | Myelodysplastic... | Erythropoietin Cyclosporin A G-CSF Prednisone | - | M.D. Anderson Cancer Center | |
| A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological Malignancies | NCT04547049 | Leukemia | Cytarabine Busulfan Cyclophosphamid... Me-CCNU Rabbit antithym... Allogeneic HSCT Cyclosporin A Mycophenolate M... MTX | 14 Years - 60 Years | First Affiliated Hospital of Zhejiang University | |
| Donor Natural Killer Cells and Aldesleukin in Treating Patients w/High Risk AML Undergoing Donor Stem Cell Transplant | NCT00303667 | Acute Myelogeno... | aldesleukin natural killer ... cyclophosphamid... fludarabine pho... allogeneic hema... total body irra... Thymoglobulin Cyclosporin A cyclophosphamid... fludarabine pho... | 18 Years - 70 Years | Masonic Cancer Center, University of Minnesota |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
